quinomycin

RN given refers to cpd with unknown MF; see also echinomycin for quinomycin A: 512-64-1; structure

Also Known As:

quinomycin B; quinomycin C; quinomycin D; quinomycin E; quinomycins; Quinomycin

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

1.	Anant, Shrikant: 1 article (01/2016)
2.	Balakrishnan, Arun: 1 article (01/2016)
3.	Dandawate, Prasad R: 1 article (01/2016)
4.	Dhar, Animesh: 1 article (01/2016)
5.	Jensen, Roy A: 1 article (01/2016)
6.	Mahajan, Girish: 1 article (01/2016)
7.	Mishra, Prabhu Dutt: 1 article (01/2016)
8.	Padhye, Subhash B: 1 article (01/2016)
9.	Parab, Rajashri R: 1 article (01/2016)
10.	Ponnurangam, Sivapriya: 1 article (01/2016)

1.	Pancreatic Neoplasms (Pancreatic Cancer) 01/19/2016 - "Quinomycin treatment resulted in significant inhibition of proliferation and colony formation in pancreatic cancer cell lines, but not in normal pancreatic epithelial cells. " 01/19/2016 - "Together, these data suggest that Quinomycin is a potent inhibitor of pancreatic cancer that targets the stem cells by inhibiting Notch signaling proteins. "
2.	Neoplasms (Cancer) 01/19/2016 - "To determine the effect of Quinomycin on tumor growth in vivo, nude mice carrying tumor xenografts were administered Quinomycin intraperitoneally every day for 21 days. "
3.	Leukemia 07/01/1988 - "However, tautomycin did not induce nitroblue tetrazolium reducing activity, when HL60 human promyelocytic leukemia cells were caused to differentiate by quinomycin into mature granulocytes. "